1.
Correction of Experimental Hypertensive Neuroretinopathy with Semax. Journal of Pharmaceutical Negative Results [Internet]. 2022 Sep. 20 [cited 2026 Jun. 13];13(3):41-5. Available from: https://mail.pnrjournal.com/index.php/home/article/view/220